President Biden will likely turn to lowering drug prices once the COVID-19 pandemic stops demanding so much of his attention, Donna Shalala, U.S. Health and Human Services (HHS) Secretary during both of President Clinton’s terms in office, predicted in a question-and-answer session yesterday during the 340B Coalition winter conference. Shalala also served in Congress until 2020.
Shalala was HHS Secretary during the implementation of the 340B drug discount program. She said she has always been supportive of the program and is well aware of its importance due to her many years living in Miami. After her HHS tenure, she served as President of University of Miami. She referenced Jackson Health System, the 340B hospital in her former congressional district, and the health centers in South Florida as playing an important role in educating her on the topic.
President Biden will likely turn to lowering drug prices once the COVID-19 pandemic stops demanding so much of his attention, Donna Shalala, U.S. Health and Human Services (HHS) Secretary during both of President Clinton’s terms in office, predicted in a question-and-answer session yesterday during the 340B Coalition winter conference.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.